Within this family, LGALS1, LGALS3, and LGALS9 have been most consistently implicated in glioblastoma progression, through roles in tumour proliferation, immune evasion, and resistance to therapy [9,10,11,12,13]. Here, LGALS1 is linked to glioblastoma.